Deletion of junctional adhesion molecule A from platelets increases early-stage neointima formation after wire injury in hyperlipidemic mice

Journal of Cellular and Molecular Medicine

Volumn 21, Issue 8, 2017, Pages 1523-1531

  Zhao, Zhen ^a,b   Vajen, Tanja ^c   Karshovska, Ela ^a   Dickhout, Annemiek ^c   Schmitt, Martin M ^a   Megens, Remco T A ^a,c   von Hundelshausen, Philipp ^a   Koeppel, Thomas A ^b   Hackeng, Tilman M ^c   Weber, Christian ^a,c,d   Koenen, Rory R ^a,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

junctional adhesion molecule; leucocyte; neointima; platelet

Indexed keywords

JUNCTIONAL ADHESION MOLECULE A; MEMBRANE PROTEIN; PADGEM PROTEIN; VON WILLEBRAND FACTOR; APOLIPOPROTEIN E; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; F11R PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY INJURY; CELL ADHESION; CELL ASSAY; CELL PROLIFERATION; CELL RECRUITMENT ASSAY; CONTROLLED STUDY; ENDOTHELIALIZATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GAIN OF FUNCTION MUTATION; HISTOGENESIS; HISTOLOGY; HYPERLIPIDEMIA; INTIMA; LASER MICROSCOPY; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CELL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; ANIMAL; ATHEROSCLEROSIS; C57BL MOUSE; CAROTID ARTERY; COMPLICATION; DEFICIENCY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; MONOCYTE; PATHOLOGY; SIGNAL TRANSDUCTION; VASCULAR REMODELING;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOOD PLATELETS; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL ADHESION; CELL ADHESION MOLECULES; FEMALE; GENE EXPRESSION REGULATION; HYPERLIPIDEMIAS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; VASCULAR REMODELING;

EID: 85013421517     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.13083     Document Type: Article

References (34)

1. Weber C, Fraemohs L, Dejana E. The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol. 2007; 7: 467–77.
2. Garrido-Urbani S, Bradfield PF, Imhof BA. Tight junction dynamics: the role of junctional adhesion molecules (JAMs). Cell Tissue Res. 2014; 355: 701–15.
3. Nourshargh S, Krombach F, Dejana E. The role of JAM-A and PECAM-1 in modulating leukocyte infiltration in inflamed and ischemic tissues. J Leukoc Biol. 2006; 80: 714–8.
4. Ozaki H, Ishii K, Horiuchi H, et al. Combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. J Immunol. 1999; 163: 553–7.
5. Ostermann G, Fraemohs L, Baltus T, et al. Involvement of JAM-A in mononuclear cell recruitment on inflamed or atherosclerotic endothelium: inhibition by soluble JAM-A. Arterioscler Thromb Vasc Biol. 2005; 25: 729–35.
6. Ostermann G, Weber KS, Zernecke A, et al. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol. 2002; 3: 151–8.
7. Schmitt MM, Fraemohs L, Hackeng TM, et al. Atherogenic mononuclear cell recruitment is facilitated by oxidized lipoprotein-induced endothelial junctional adhesion molecule-A redistribution. Atherosclerosis. 2014; 234: 254–64.
8. Zernecke A, Liehn EA, Fraemohs L, et al. Importance of junctional adhesion molecule-A for neointimal lesion formation and infiltration in atherosclerosis-prone mice. Arterioscler Thromb Vasc Biol. 2006; 26: e10–3.
9. Schmitt MM, Megens RT, Zernecke A, et al. Endothelial junctional adhesion molecule-a guides monocytes into flow-dependent predilection sites of atherosclerosis. Circulation. 2014; 129: 66–76.
10. Kornecki E, Walkowiak B, Naik UP, et al. Activation of human platelets by a stimulatory monoclonal antibody. J Biol Chem. 1990; 265: 10042–8.
11. Naik MU, Caplan JL, Naik UP. Junctional adhesion molecule-A suppresses platelet integrin alphaIIbbeta3 signaling by recruiting Csk to the integrin-c-Src complex. Blood. 2014; 123: 1393–402.
12. Naik MU, Stalker TJ, Brass LF, et al. JAM-A protects from thrombosis by suppressing integrin alphaIIbbeta3-dependent outside-in signaling in platelets. Blood. 2012; 119: 3352–60.
13. Karshovska E, Zhao Z, Blanchet X, et al. Hyperreactivity of junctional adhesion molecule a-deficient platelets accelerates atherosclerosis in hyperlipidemic mice. Circ Res. 2015; 116: 587–99.
14. Wang Y, Sakuma M, Chen Z, et al. Leukocyte engagement of platelet glycoprotein Ibalpha via the integrin Mac-1 is critical for the biological response to vascular injury. Circulation. 2005; 112: 2993–3000.
15. Tiedt R, Schomber T, Hao-Shen H, et al. Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo. Blood. 2007; 109: 1503–6.
16. Schober A, Manka D, von Hundelshausen P, et al. Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation. 2002; 106: 1523–9.
17. Karshovska E, Zagorac D, Zernecke A, et al. A small molecule CXCR4 antagonist inhibits neointima formation and smooth muscle progenitor cell mobilization after arterial injury. J Thromb Haemost. 2008; 6: 1812–5.
18. Karshovska E, Zernecke A, Sevilmis G, et al. Expression of HIF-1alpha in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol. 2007; 27: 2540–7.
19. Weber C, Springer TA. Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor. J Clin Invest. 1997; 100: 2085–93.
20. Ip JH, Fuster V, Badimon L, et al. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. 1990; 15: 1667–87.
21. Kuckleburg CJ, Yates CM, Kalia N, et al. Endothelial cell-borne platelet bridges selectively recruit monocytes in human and mouse models of vascular inflammation. Cardiovasc Res. 2011; 91: 134–41.
22. Shimaoka M, Springer TA. Therapeutic antagonists and conformational regulation of integrin function. Nat Rev Drug Discov. 2003; 2: 703–16.
23. Santoso S, Sachs UJ, Kroll H, et al. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med. 2002; 196: 679–91.
24. Langer HF, Bigalke B, Seizer P, et al. Interaction of platelets and inflammatory endothelium in the development and progression of coronary artery disease. Semin Thromb Hemost. 2010; 36: 131–8.
25. Weyrich AS, Elstad MR, McEver RP, et al. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest. 1996; 97: 1525–34.
26. Koenen RR. The prowess of platelets in immunity and inflammation. Thromb Haemost. 2016; 116: 605–12.
27. Kehrel B, Wierwille S, Clemetson KJ, et al. Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood. 1998; 91: 491–9.
28. Wu SP, Ringgaard S, Oyre S, et al. Wall shear rates differ between the normal carotid, femoral, and brachial arteries: an in vivo MRI study. J Magn Reson Imaging. 2004; 19: 188–93.
29. Simon DI, Chen Z, Xu H, et al. Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med. 2000; 192: 193–204.
30. Choi EY, Chavakis E, Czabanka MA, et al. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science. 2008; 322: 1101–4.
31. Shi G, Field DJ, Long X, et al. Platelet factor 4 mediates vascular smooth muscle cell injury responses. Blood. 2013; 121: 4417–27.
32. Sarabi A, Kramp BK, Drechsler M, et al. CXCL4L1 inhibits angiogenesis and induces undirected endothelial cell migration without affecting endothelial cell proliferation and monocyte recruitment. J Thromb Haemost. 2011; 9: 209–19.
33. Woodfin A, Reichel CA, Khandoga A, et al. JAM-A mediates neutrophil transmigration in a stimulus-specific manner in vivo: evidence for sequential roles for JAM-A and PECAM-1 in neutrophil transmigration. Blood. 2007; 110: 1848–56.
34. Yahagi K, Kolodgie FD, Otsuka F, et al. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nat Rev Cardiol. 2016; 13: 79–98.